CYP2C9 and colorectal adenocarcinoma: Additionally, FHC cells, derived from the human colon, and HT29 cells, derived from human colorectal adenocarcinoma, cannot express CYP2B6, CYP2C9, CYP2C19, or CYP3A4 (61).